日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Prevalence of RAS and BRAF mutations in metastatic colorectal cancer patients by tumor sidedness: A systematic review and meta-analysis

按肿瘤侧别分析转移性结直肠癌患者中 RAS 和 BRAF 突变的患病率：系统评价和荟萃分析

期刊:Cancer Medicine
影响因子:3.1
doi:10.1002/cam4.2747
Bylsma, Lauren C; Gillezeau, Christina; Garawin, Tamer A; Kelsh, Michael A; Fryzek, Jon P; Sangaré, Laura; Lowe, Kimberly A
肿瘤
肠癌
肿瘤免疫
BRAF
RAS
发表日期：2020
文献求助 收藏

A National Survey of Medical Oncologist's Opinions and Perceptions for Managing Rash Among mCRC Patients Treated with Panitumumab

一项关于肿瘤内科医生对接受帕尼单抗治疗的转移性结直肠癌患者皮疹管理的意见和看法的全国性调查

期刊:Dermatology and Therapy
影响因子:4.2
doi:10.1007/s13555-019-0296-z
Lowe, Kimberly A; Sangaré, Laura; Bergstresser, Rachel; McNamara, Michelle; Kafatos, George; Garawin, Tamer
肿瘤
肠癌
肿瘤免疫
发表日期：2019
文献求助 收藏

Dermatologic Toxicity Occurring During Anti-EGFR Monoclonal Inhibitor Therapy in Patients With Metastatic Colorectal Cancer: A Systematic Review

转移性结直肠癌患者接受抗EGFR单克隆抑制剂治疗期间发生的皮肤毒性：系统评价

期刊:Clinical Colorectal Cancer
影响因子:3.2
doi:10.1016/j.clcc.2017.12.004
Lacouture, Mario E; Anadkat, Milan; Jatoi, Aminah; Garawin, Tamer; Bohac, Chet; Mitchell, Edith
肿瘤
肠癌
肿瘤免疫
EGF
EGFR
毒理研究
发表日期：2018
文献求助 收藏

RAS mutation prevalence among patients with metastatic colorectal cancer: a meta-analysis of real-world data

转移性结直肠癌患者中RAS突变患病率：一项基于真实世界数据的荟萃分析

期刊:Biomarkers in Medicine
影响因子:2.1
doi:10.2217/bmm-2016-0358
Kafatos, George; Niepel, Daniela; Lowe, Kimberley; Jenkins-Anderson, Sophie; Westhead, Hal; Garawin, Tamer; Traugottová, Zuzana; Bilalis, Antonios; Molnar, Edit; Timar, Jozsef; Toth, Erika; Gouvas, Nikolaos; Papaxoinis, George; Murray, Samuel; Mokhtar, Nadia; Vosmikova, Hana; Fabian, Pavel; Skalova, Alena; Wójcik, Piotr; Tysarowski, Andrzej; Barugel, Mario; van Krieken, J Han; Trojan, Jörg
RAS
肿瘤
肠癌
肿瘤免疫
发表日期：2017
文献求助 收藏